Xtrem Biotech
-
DATABASE (95)
-
ARTICLES (44)
Established in September 2016, Chobe Capital is based in Shanghai. The firm is a registered private equity manager, focusing on pre-IPO and VC projects. Chobe Capital mainly invests in various sectors like TMT, biotechnology, consumer products and environmental protection.
Established in September 2016, Chobe Capital is based in Shanghai. The firm is a registered private equity manager, focusing on pre-IPO and VC projects. Chobe Capital mainly invests in various sectors like TMT, biotechnology, consumer products and environmental protection.
B Capital Group is best known as the venture capital firm co-founded by Eduardo Saverin, co-founder of Facebook. Its investment thesis focuses on connecting highly innovative and agile startups with major corporates that are in need of innovation and have the resources to innovate. As such, B Capital has a special interest in B2B companies that have great potential to disrupt critical industries. This includes startups that are disrupting healthcare and biotechnology, as well as finance and insurance. B Capital has also supported some notable B2C companies, including coffee chain Kopi Kenangan and used car marketplace Carro.
B Capital Group is best known as the venture capital firm co-founded by Eduardo Saverin, co-founder of Facebook. Its investment thesis focuses on connecting highly innovative and agile startups with major corporates that are in need of innovation and have the resources to innovate. As such, B Capital has a special interest in B2B companies that have great potential to disrupt critical industries. This includes startups that are disrupting healthcare and biotechnology, as well as finance and insurance. B Capital has also supported some notable B2C companies, including coffee chain Kopi Kenangan and used car marketplace Carro.
Headquartered in Shanghai, FC Capital was founded in 2017 to focus on investments in China and the US. The VC mainly invests in medtech sectors like biotechnology, medical devices, medical services and health-related consumer products.
Headquartered in Shanghai, FC Capital was founded in 2017 to focus on investments in China and the US. The VC mainly invests in medtech sectors like biotechnology, medical devices, medical services and health-related consumer products.
Zhongguancun Longmen Investment
Investing in hi-tech IT, advanced manufacturing and biotechnology sectors – key pillars of China’s innovation-focused economy since 2017 – the Beijing government-backed Beijing Zhongguancun Longmen Investment manages about RMB 10bn via its first fund of the same name. The firm is founded and led by Xu Jinghong, former Chairman of Tsinghua Holdings, the investment and tech/R&D transfer arm of China’s most prestigious science and research university, whose R&D capacity was ranked in the third place of China’s top 500 enterprises in 2018. The LPs of the fund include social security funds, Beijing’s municipal government and the Haidian District government. Its portfolio enterprises are generally ranked in the top three of their respective industries. Among them, Qi An Xin Technology, which is listed in Shanghai and one of China’s biggest cybersecurity companies; Joy Wing Mao, one of China’s major fruits supply chain companies. In October of 2020, it invested RMB 100m into Beijing Immunochina Pharmaceutical, which develops innovative gene and cell therapies for curing malignant tumors. Longmen also provides mentoring and other expertise and support to its investee startups, especially those that plan to seek public listing.
Investing in hi-tech IT, advanced manufacturing and biotechnology sectors – key pillars of China’s innovation-focused economy since 2017 – the Beijing government-backed Beijing Zhongguancun Longmen Investment manages about RMB 10bn via its first fund of the same name. The firm is founded and led by Xu Jinghong, former Chairman of Tsinghua Holdings, the investment and tech/R&D transfer arm of China’s most prestigious science and research university, whose R&D capacity was ranked in the third place of China’s top 500 enterprises in 2018. The LPs of the fund include social security funds, Beijing’s municipal government and the Haidian District government. Its portfolio enterprises are generally ranked in the top three of their respective industries. Among them, Qi An Xin Technology, which is listed in Shanghai and one of China’s biggest cybersecurity companies; Joy Wing Mao, one of China’s major fruits supply chain companies. In October of 2020, it invested RMB 100m into Beijing Immunochina Pharmaceutical, which develops innovative gene and cell therapies for curing malignant tumors. Longmen also provides mentoring and other expertise and support to its investee startups, especially those that plan to seek public listing.
Juan García Perrote is an IESE Business School MBA graduate with over 10 years of experience in executive marketing roles. He is also serial entrepreneur in marketplace and digital marketing startups. He was the co-founder of Tick4all, the “last-minute of movie-tickets,” offering discounted seats at local cinemas, and COO of the referral marketing platform Fulltip. He was also partner and CEO of the digital marketing company Smart Client.Currently, he is CEO and founder of Ketplace, a marketplace sales management consultancy advising companies how to get the best sales performance in leading marketplaces such as Amazon, eBay, and AliExpress. García Perrote is also a partner and advisor in The Beemine Lab, the first biotechnology company in Spain to produce cannabidiol-based cosmetics.
Juan García Perrote is an IESE Business School MBA graduate with over 10 years of experience in executive marketing roles. He is also serial entrepreneur in marketplace and digital marketing startups. He was the co-founder of Tick4all, the “last-minute of movie-tickets,” offering discounted seats at local cinemas, and COO of the referral marketing platform Fulltip. He was also partner and CEO of the digital marketing company Smart Client.Currently, he is CEO and founder of Ketplace, a marketplace sales management consultancy advising companies how to get the best sales performance in leading marketplaces such as Amazon, eBay, and AliExpress. García Perrote is also a partner and advisor in The Beemine Lab, the first biotechnology company in Spain to produce cannabidiol-based cosmetics.
LeapFrog Investments is an impact-focused investor, managing over $1.6bn in assets mainly investing in Africa and Asia. Its “profit with purpose” has led to investments in startups that provide healthcare, financial services and insurance for low-income consumers. Since it was founded in 2007, LeapFrog has attracted funds from Prudential, AXA, Swiss Re and Omidyar Network, becoming the first impact investor in the world to reach the $1bn milestone. It’s headquartered in South Africa and Singapore.LeapFrog is best known for its investments in the insurance sector. One of the most prominent companies in its portfolio is BIMA, the mobile-based insurance provider that has provided coverage in Ghana, Bangladesh, Cambodia and many other countries. In 2020, LeapFrog invested in Indonesian startup PasarPolis, which is a broker for a wide range of microinsurance products. In the healthcare and biotechnology sectors, LeapFrog has funded Indian genetic diagnostics company MedGenome, as well as Goodlife Pharmacy, a Kenyan company providing access to affordable medicine in the East African country.
LeapFrog Investments is an impact-focused investor, managing over $1.6bn in assets mainly investing in Africa and Asia. Its “profit with purpose” has led to investments in startups that provide healthcare, financial services and insurance for low-income consumers. Since it was founded in 2007, LeapFrog has attracted funds from Prudential, AXA, Swiss Re and Omidyar Network, becoming the first impact investor in the world to reach the $1bn milestone. It’s headquartered in South Africa and Singapore.LeapFrog is best known for its investments in the insurance sector. One of the most prominent companies in its portfolio is BIMA, the mobile-based insurance provider that has provided coverage in Ghana, Bangladesh, Cambodia and many other countries. In 2020, LeapFrog invested in Indonesian startup PasarPolis, which is a broker for a wide range of microinsurance products. In the healthcare and biotechnology sectors, LeapFrog has funded Indian genetic diagnostics company MedGenome, as well as Goodlife Pharmacy, a Kenyan company providing access to affordable medicine in the East African country.
Beijing Zhongguancun Development Qihang Industrial Investment Fund
Beijing Zhongguancun Development Qihang Industrial Investment Fund was launched by Zhongguancun Development Group, a hi-tech commercialization platform backed by the municipal government of Beijing. It focuses on biotechnology, pharmaceuticals, next-generation information technology, new energy, new materials and intelligent manufacturing.
Beijing Zhongguancun Development Qihang Industrial Investment Fund was launched by Zhongguancun Development Group, a hi-tech commercialization platform backed by the municipal government of Beijing. It focuses on biotechnology, pharmaceuticals, next-generation information technology, new energy, new materials and intelligent manufacturing.
Beijing Zhongguancun Development Frontier Enterprise Investment Fund
Beijing Zhongguancun Development Frontier Enterprise Investment Fund was launched by Zhongguancun Development Group, a hi-tech commercialization platform backed by the municipal government of Beijing. It focuses on artificial intelligence and big data, mainly investing in sectors like industrial internet, connected vehicles, biotechnology and healthcare.
Beijing Zhongguancun Development Frontier Enterprise Investment Fund was launched by Zhongguancun Development Group, a hi-tech commercialization platform backed by the municipal government of Beijing. It focuses on artificial intelligence and big data, mainly investing in sectors like industrial internet, connected vehicles, biotechnology and healthcare.
Beyond Investing is a Geneva-based firm investing in early-stage venture capital and equity growth startups mainly in European developed markets. With average investments of €200,000, the firm’s core investment strategy focuses on sustainability with an investment period lasting 5–10 years.The impact investor targets innovative startups involved in vegan, cruelty-free and plant-based alternatives; biotechnologies, foodtech, new materials, clothing and lifestyle sectors. Successful portfolio foodtechs include Mosa Meat, BlueNalu and Shiok Meats.With a team of vegan finance professionals in the US and Europe, Beyond Investing listed the first US Vegan Climate ETF (VEGN) on the New York Stock Exchange in September 2019. The ETF tracks Beyond Investing’s US Vegan Climate Index which covers an index of 495 of the largest-capitalization companies in the US stock market. The ethical investment option aims to exclude stocks in companies with activities that are not aligned with its vegan-themed, cruelty-free and fossil-fuel-free investing ethos.
Beyond Investing is a Geneva-based firm investing in early-stage venture capital and equity growth startups mainly in European developed markets. With average investments of €200,000, the firm’s core investment strategy focuses on sustainability with an investment period lasting 5–10 years.The impact investor targets innovative startups involved in vegan, cruelty-free and plant-based alternatives; biotechnologies, foodtech, new materials, clothing and lifestyle sectors. Successful portfolio foodtechs include Mosa Meat, BlueNalu and Shiok Meats.With a team of vegan finance professionals in the US and Europe, Beyond Investing listed the first US Vegan Climate ETF (VEGN) on the New York Stock Exchange in September 2019. The ETF tracks Beyond Investing’s US Vegan Climate Index which covers an index of 495 of the largest-capitalization companies in the US stock market. The ethical investment option aims to exclude stocks in companies with activities that are not aligned with its vegan-themed, cruelty-free and fossil-fuel-free investing ethos.
Based in San Mateo California, KBW Ventures was founded by HRH Prince Khaled bin Alwaleed bin Talal Al Saud. The asset management firm’s CEO is also the chairman of KBW Investments that was founded in 2013 in Dubai in the United Arab Emirates (UAE).KBW Ventures is part of the KBW Group and mainly invests in companies involved in sustainable food, artificial intelligence, blockchain technologies and fintech. In 2019, the VC had already invested in 24 companies in sectors like e-gaming, drones, e-commerce and plant-based proteins. Recently, it also increased its stakes in two Californian biotechs BlueNalu and TurtleTree Labs. The aim is to open up the Middle East markets to global tech companies.
Based in San Mateo California, KBW Ventures was founded by HRH Prince Khaled bin Alwaleed bin Talal Al Saud. The asset management firm’s CEO is also the chairman of KBW Investments that was founded in 2013 in Dubai in the United Arab Emirates (UAE).KBW Ventures is part of the KBW Group and mainly invests in companies involved in sustainable food, artificial intelligence, blockchain technologies and fintech. In 2019, the VC had already invested in 24 companies in sectors like e-gaming, drones, e-commerce and plant-based proteins. Recently, it also increased its stakes in two Californian biotechs BlueNalu and TurtleTree Labs. The aim is to open up the Middle East markets to global tech companies.
Founded in 2016, Paris-based Future Positive Capital invests in European startups in deep tech and biotechnology to solve major problems, with funding for only 20 portfolio startups. It has backed eight startups to date with its most recent investments being in the April 2021 undisclosed €5.2m funding round of French renewable energytech SWEETCH Energy and in the £7.9m Series A round of British ecosystem restoration technology Dendra Systems in September 2020.
Founded in 2016, Paris-based Future Positive Capital invests in European startups in deep tech and biotechnology to solve major problems, with funding for only 20 portfolio startups. It has backed eight startups to date with its most recent investments being in the April 2021 undisclosed €5.2m funding round of French renewable energytech SWEETCH Energy and in the £7.9m Series A round of British ecosystem restoration technology Dendra Systems in September 2020.
Samsung Venture Investment, or Samsung Ventures, is the VC investment arm of South Korean diversified conglomerate Samsung Group. It is a separate entity from Samsung NEXT.Samsung Ventures primarily invests in semiconductors, telecommunications tech, software and internet companies, as well as biotechnology and medical companies. The VC is built to support new innovations that can lead to further improvements in Samsung’s existing businesses, which includes smartphones, home appliances, and components like OLED panels and Li-ion batteries.Samsung Ventures has invested in healthcare and wellness tech companies like Indonesia’s telehealth service Alodokter, posture correction device makers Posture360, and Noom, an app for dieting and exercise. In the sensors front, Samsung Ventures has invested in Sense Photonics, a startup creating 3D computer vision based on lidar for industrial and automotive (self-driving) purposes. Besides these companies, Samsung Ventures has also invested in insurtech companies and even gaming companies, such as Pokémon Go developer Niantic.
Samsung Venture Investment, or Samsung Ventures, is the VC investment arm of South Korean diversified conglomerate Samsung Group. It is a separate entity from Samsung NEXT.Samsung Ventures primarily invests in semiconductors, telecommunications tech, software and internet companies, as well as biotechnology and medical companies. The VC is built to support new innovations that can lead to further improvements in Samsung’s existing businesses, which includes smartphones, home appliances, and components like OLED panels and Li-ion batteries.Samsung Ventures has invested in healthcare and wellness tech companies like Indonesia’s telehealth service Alodokter, posture correction device makers Posture360, and Noom, an app for dieting and exercise. In the sensors front, Samsung Ventures has invested in Sense Photonics, a startup creating 3D computer vision based on lidar for industrial and automotive (self-driving) purposes. Besides these companies, Samsung Ventures has also invested in insurtech companies and even gaming companies, such as Pokémon Go developer Niantic.
Established in 1996, SBI Investment is a venture capital firm that focuses on growth sectors such as information technology, biotechnology, life science, mobile, environment and energy. The VC arm of the SBI Group is developed to quickly find new, emerging technologies and investing in those technologies to further the development of the group. SBI Group then introduces the new technologies to existing businesses in order to help them stay ahead in the market, as well as to revitalize local industries in Japan, particularly in the financial and banking sectors.
Established in 1996, SBI Investment is a venture capital firm that focuses on growth sectors such as information technology, biotechnology, life science, mobile, environment and energy. The VC arm of the SBI Group is developed to quickly find new, emerging technologies and investing in those technologies to further the development of the group. SBI Group then introduces the new technologies to existing businesses in order to help them stay ahead in the market, as well as to revitalize local industries in Japan, particularly in the financial and banking sectors.
American investment capital firm Farallon Capital Management was established in 1986. The company manages equity capital for institutions, including college endowments, charitable foundations and pension plans, and funds for high net worth individuals. While most of its investments are in risk arbitrage and debt restructuring, it has also invested in startups across different verticals, such as Indonesian ride-hailing firm Gojek and a host of biotechnology, pharmaceuticals and medical technology companies.Farallon’s history with Indonesia began long before Gojek came into existence. In 2002, Farallon bought a controlling stake in Bank Central Asia (BCA), an Indonesian bank, during a time when investors avoided Indonesian banks that had been saddled with bad debt. With the controlling stake, Farallon installed a new bank chairman and reformed BCA. Over the next four years Farallon slowly divested in BCA and finally sold the remaining 4% stake in 2006 to earn a profit.
American investment capital firm Farallon Capital Management was established in 1986. The company manages equity capital for institutions, including college endowments, charitable foundations and pension plans, and funds for high net worth individuals. While most of its investments are in risk arbitrage and debt restructuring, it has also invested in startups across different verticals, such as Indonesian ride-hailing firm Gojek and a host of biotechnology, pharmaceuticals and medical technology companies.Farallon’s history with Indonesia began long before Gojek came into existence. In 2002, Farallon bought a controlling stake in Bank Central Asia (BCA), an Indonesian bank, during a time when investors avoided Indonesian banks that had been saddled with bad debt. With the controlling stake, Farallon installed a new bank chairman and reformed BCA. Over the next four years Farallon slowly divested in BCA and finally sold the remaining 4% stake in 2006 to earn a profit.
Singapore's government-owned investor has a net portfolio value of just over S$300bn, with assets mainly in Asia and Singapore. In recent years it has begun investing in internet and tech companies in emerging markets, including in neighboring Indonesia and other Asian countries.As a state investor, Temasek aligns its investment portfolio and goals with areas that are relevant to Singapore’s national agenda. For example, to mitigate and reduce the effects of climate change, Temasek has set a commitment to reduce the carbon emissions of its portfolio companies, and invest in companies providing decarbonization solutions. It is also investing in biotechnology, medical technology, agritech and foodtech companies, which are some new focus areas in Singapore’s industrial development.
Singapore's government-owned investor has a net portfolio value of just over S$300bn, with assets mainly in Asia and Singapore. In recent years it has begun investing in internet and tech companies in emerging markets, including in neighboring Indonesia and other Asian countries.As a state investor, Temasek aligns its investment portfolio and goals with areas that are relevant to Singapore’s national agenda. For example, to mitigate and reduce the effects of climate change, Temasek has set a commitment to reduce the carbon emissions of its portfolio companies, and invest in companies providing decarbonization solutions. It is also investing in biotechnology, medical technology, agritech and foodtech companies, which are some new focus areas in Singapore’s industrial development.
Xtrem Biotech, an agritech startup from Granada, seeks global expansion
With its research roots in the University of Granada, Xtrem Biotech was named one of the world's most innovative agtech spin-offs by accelerator TERRA Food & AgTech
Daniel Oliver: Building a "Facebook" for investments in biotech startups
The biologist and crowdfunding expert has pioneered the growth of Spanish biotech startups, providing access to early-stage investments, with support from scientific experts worldwide
Meatable: Cell-based meat startup secures $47m Series A for scalable technology
The Dutch startup offers a pioneering technology for quickly scaling cell-based meat production while eliminating the need for animal-derived growth media
Forget solar panels and batteries, Bioo wants to scale soil bioelectricity generation
Improving on NASA’s microbial fuel cell tech, Bioo hopes to boost crop efficiency and transform the way urbanites live, in future green cities powered by plants
TurtleTree Labs: Creating sustainable mammalian milk alternatives from stem cells
Founder’s search for high-quality dairy milk led to the creation in a lab of naturally occurring ingredients found in human milk for supply to dairy milk and infant formula businesses
Sequoia Capital China holds steady with investments in healthcare, biotech and green economy
China’s most active investor increases bets on sectors beyond the consumer internet and edtech recently hurt by regulatory clampdown
Because Animals: Pioneering cultured meat for pets
The biotech startup is disrupting the pet food processing industry with cell-based food to minimize environmental “pawprints” and promote animal welfare
NovoNutrients: Tackling the dual problems of CO2 emissions and over-fishing
The first to transform CO2 to fish food, NovoNutrients is trialing with industry giants Skretting and Chevron, and will soon raise Series A funding
Poliloop: Tackling pollution crisis with plastic-eating bacteria for industrial use
Hungarian biotech Poliloop is closing $2m seed funding for “bacteria cocktail” that breaks down plastic into organic waste quickly, enabling more affordable and eco-friendly waste management
Qorium: Lab-grown premium leather for the future of luxury
The Dutch biotech startup co-founded by cell-based meat pioneer Mark Post is targeting the luxury goods market with its “clean leather” sheets made from cultivating bovine skin cells, and plans to raise up to €100m
Mycorena: Fungi-based vegan protein challenging traditional plant-based ingredients
Award-winning Swedish biotech startup is scaling production of mycoprotein to become a key player in the emerging market for functional proteins
TreeFrog Therapeutics: Mimicking how stem cells grow in the human body
The French biotech’s proprietory technology to cultivate pluripotent stem cells in a 3D environment can be scaled to mass-produce high-quality cells to treat diseases such as Parkinson’s
New Food Invest: Opportunities in the European alt-protein space
With a record €2.4bn investment in 2019, Europe’s foodtech sector appears poised for continued growth, but startups, corporations, governments and even universities can do more, experts say
Future Food Asia by ID Capital: Introducing Asia's agrifood startups to the world
More than a meeting of startups and investors, the conference showcases ID Capital’s investment thesis and Big Ag’s support for agrifood tech in the world’s most populous region
Cubiq Foods: Bioreactor farms producing the food of tomorrow
Growing appetite for meat alternatives expected to fuel demand for Cubiq’s low calorie, Omega 3-enriched lab-grown fats
Sorry, we couldn’t find any matches for “Xtrem Biotech”.
POPULAR DATABASE
